Literature DB >> 14690681

A fluorescence-based assay for multisubunit DNA-dependent RNA polymerases.

Peter Kuhlman1, Heidi L Duff, Ashley Galant.   

Abstract

The properties of DNA-dependent RNA polymerases have been studied since the 1960s, but considerable interest in probing RNA polymerase structure/function relationships, the roles of different classes of RNA polymerases in cellular processes, and the feasibility of using RNA polymerases as drug targets still exists. Historically, RNA polymerase activity has been measured by the incorporation into RNA of radioisotopically labeled nucleotides. We report the development of an assay for RNA polymerase activity that uses the dye RiboGreen to detect transcripts by fluorescence and is thus free of the expense, short shelf life, and high handling costs of radioisotopes. The method is relatively quick and can be performed entirely in microplate format, allowing for the processing of dozens to hundreds of samples in parallel. It should thus be well-suited to use in drug screening and analysis of chromatographic fractions. As RiboGreen fluorescence is enhanced by binding to either RNA or DNA, template DNA must be removed by DNase digestion and ultrafiltration between the transcription and the detection phases of the assay procedure. Although RiboGreen fluorescence is sensitive to changes in solvent environment, solvent exchange in the ultrafiltration step allows comparison of transcription levels even under extremes of salt, pH, etc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14690681     DOI: 10.1016/j.ab.2003.08.038

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor.

Authors:  Scott S Walker; David Degen; Elliott Nickbarg; Donna Carr; Aileen Soriano; Mihir Mandal; Ronald E Painter; Payal Sheth; Li Xiao; Xinwei Sher; Nicholas Murgolo; Jing Su; David B Olsen; Richard H Ebright; Katherine Young
Journal:  ACS Chem Biol       Date:  2017-03-31       Impact factor: 5.100

Review 2.  New target for inhibition of bacterial RNA polymerase: 'switch region'.

Authors:  Aashish Srivastava; Meliza Talaue; Shuang Liu; David Degen; Richard Y Ebright; Elena Sineva; Anirban Chakraborty; Sergey Y Druzhinin; Sujoy Chatterjee; Jayanta Mukhopadhyay; Yon W Ebright; Alex Zozula; Juan Shen; Sonali Sengupta; Rui Rong Niedfeldt; Cai Xin; Takushi Kaneko; Herbert Irschik; Rolf Jansen; Stefano Donadio; Nancy Connell; Richard H Ebright
Journal:  Curr Opin Microbiol       Date:  2011-08-19       Impact factor: 7.934

3.  GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides.

Authors:  Yu Zhang; David Degen; Mary X Ho; Elena Sineva; Katherine Y Ebright; Yon W Ebright; Vladimir Mekler; Hanif Vahedian-Movahed; Yu Feng; Ruiheng Yin; Steve Tuske; Herbert Irschik; Rolf Jansen; Sonia Maffioli; Stefano Donadio; Eddy Arnold; Richard H Ebright
Journal:  Elife       Date:  2014-04-22       Impact factor: 8.140

4.  Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Bajoie Wan; Scott G Franzblau; Michio Kurosu
Journal:  J Antibiot (Tokyo)       Date:  2014-10-01       Impact factor: 2.649

5.  Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp.

Authors:  Hossam M Hassan; David Degen; Kyoung Hwa Jang; Richard H Ebright; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2014-09-17       Impact factor: 2.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.